Fortis Malar Hospitals Limited has issued an official clarification to BSE Limited regarding an erroneous regulatory filing that was inadvertently reported under the company's name on January 2, 2026.

Filing Details and Clarification

The clarification, dated January 7, 2026, addresses a specific announcement that was titled "Disclosure under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)". According to the company's communication to BSE, this announcement was mistakenly attributed to Fortis Malar Hospitals Limited when it actually pertains to another group company.

Company Communication

The clarification was signed by Vinti Verma, Company Secretary & Compliance Officer (Membership No.: A44528), who digitally signed the document on January 7, 2026. The company has specifically requested shareholders to ignore the January 2, 2026 announcement as it does not relate to Fortis Malar Hospitals Limited's operations or disclosures.

Regulatory Context

The erroneous filing was originally categorized under Regulation 30 of SEBI Listing Regulations, which governs disclosure of material events and information by listed companies. Such clarifications are important for maintaining transparency and ensuring that investors have accurate information about the company's actual disclosures and material events.

Shareholder Advisory

Fortis Malar Hospitals Limited has advised its shareholders to disregard the January 2, 2026 announcement entirely. The company emphasized that this clarification serves as official information for shareholders' records and requested them to treat only legitimate company announcements as valid disclosures going forward.

Fortis Healthcare Limited has informed stock exchanges about a significant GST order received by its wholly owned subsidiary, Fortis Health Management Limited, demanding ₹597.93 crores including interest and penalty for the financial year 2023-24.

GST Order Details

The State Tax Officer (ST)- Group IX, Chengalpattu Intelligence Division, Tamil Nadu issued the GST order on January 02, 2026. The order follows a show cause notice that was initially issued for ₹570.00 crores, including a penalty of ₹285.00 crores.

Nature of Dispute

The GST authority has denied the healthcare service exemption claimed by the company. According to the disclosure, the GST exemption of healthcare service claimed by Fortis Health Management Limited has been rejected, leading to the demand confirmation.

Company's Response

Fortis Healthcare has indicated that after submission of response by Fortis Health Management Limited, the GST Authority passed the order confirming the higher demand amount. The show cause notice in relation to the balance amount has been dropped by the authorities.

Financial Impact Assessment

The company has assessed that the demand is not maintainable and is in the process of filing an appeal against the order. Management has stated that it does not envisage any relevant impact on the financials, operations, or other activities of the company.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company provided detailed annexures covering the litigation details and penalty information as required under the regulatory framework.

The disclosure was signed by Satyendra Chauhan, Company Secretary & Compliance Officer, and submitted to both NSE and BSE on January 02, 2026.